Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders

[1]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[2]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[3]  Tomas W. Fitzgerald,et al.  Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing , 2016, Nature Genetics.

[4]  J. Rosenfeld,et al.  POGZ truncating alleles cause syndromic intellectual disability , 2016, Genome Medicine.

[5]  A. Shilatifard,et al.  Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing , 2015, Molecular and Cellular Biology.

[6]  Chun-Kai Huang,et al.  Cdk12 and Cdk13 regulate axonal elongation through a common signaling pathway that modulates Cdk5 expression , 2014, Experimental Neurology.

[7]  Long Yu,et al.  Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages , 2014, BMC Evolutionary Biology.

[8]  J. Kohoutek,et al.  Cyclin K goes with Cdk12 and Cdk13 , 2012, Cell Division.

[9]  Jernej Ule,et al.  The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. , 2011, Genes & development.

[10]  Li-Huei Tsai,et al.  Cyclin-dependent kinases: a family portrait , 2009, Nature Cell Biology.

[11]  A. Genevière,et al.  A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. , 2000, Biochemical and biophysical research communications.